NCT06256055 2024-07-24Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsUTC Therapeutics Inc.Phase 1 Unknown24 enrolled
NCT03507998 2020-07-24Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal TumorsCuregenix Inc.Phase 1 Unknown39 enrolled